Derivatives house of the year: JP Morgan

Daniel Pinto

JP Morgan is not the world’s most popular bank. Its chief executive, Jamie Dimon, spent 2011 jousting with regulators – including his now-famous cross-examination of Federal Reserve chairman, Ben Bernanke, at a conference in Atlanta – sometimes calling for the rule-makers to step back, and sometimes calling for them to iron out transatlantic differences. His outspokenness, unique among bank chief executives, may have won him friends in the media and on Wall Street, but did not endear the firm to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Environmental products house of the year: ENGIE

ENGIE is driving change in energy transition, with a strong focus on renewable energy and the liberalisation of power markets in Apac, which presents significant long-term growth opportunities. In recognition of its efforts, ENGIE GEMS has been named…

Newcomer of the year: Topaz Technology

Jon Fox and former colleagues formed Topaz Technology in 2015. Having seen many different systems and, in some cases, written and built a few themselves, there was always something missing, leading them to build a system that unifies risk reporting and…

Technology vendor of the year: Murex

As a technology vendor, Murex places adaptability front and centre of everything it does, constantly enriching its MX.3 platform to ensure institutions can respond to new market opportunities as soon as they spot them

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here